A highly significant discovery in the healthcare field is reflected in a report published last week by federal health officials. The report revealed a steady decline in the incidence of hospital-acquired infections (HAIs) in US-based hospitals throughout 2024, marking a continuous drawback from figures unique to the COVID-19 pandemic period. These conclusions were drawn from data collated by the National Healthcare Safety Network (NHSN) of the Centers for Disease Control and Prevention (CDC).
According to the data, most HAIs saw a deliberate decline across the spectrum of US acute care hospitals between 2023 and 2024. This trend was particularly noticeable in the occurrence of central line-associated bloodstream infections and catheter-associated urinary tract infections (CAUTIs), which both saw a noteworthy reduction of 9% and 10% respectively. Moreover, the report highlighted an 11% downturn in hospital-onset Clostridioides difficile infections throughout acute care hospitals, accompanied by a 7% decrement in methicillin-resistant Staphylococcus aureus bacteremia, a 4% drop in post-colon surgery surgical site infections, and a minor 2% reduction in Ventilator-associated events (VAEs).
Additionally, data reflected a significant improvement in other healthcare settings. Long-term acute care hospitals, for example, which care for critically ill individuals and are perceived as high-risk environments for HAIs, reported a 23% and 15% decrease in VAEs and C difficile infections respectively. In comparison, inpatient rehabilitation facilities reported an 18% fall in C difficile cases and an 8% decline in CAUTIs. This downward trend also extended to state-level performance in 2024, with 17 states displaying enhanced performance in mitigating at least two types of infections compared to their 2023 figures, and a total of 50 states showing improvements from their 2015 baseline data.
The CDC continues to emphasize the necessity for hospitals to bolster infection prevention and control (IPC) measures. The CDC remains committed to continuous prevention, tracking, lab, and applied research activities as part of their mission to eliminate HAIs, emphasizing that “while much progress has been made, more needs to be done”.